Pembrolizumab plus chemotherapy for advanced non-small-cell lung cancer without tumor PD-L1 expression in Asia

Immunotherapy,Volume 15, Issue 13, Page 1029-1044, September 2023.
Source: Immunotherapy - Category: Allergy & Immunology Authors: Source Type: research